US OptionsDetailed Quotes
MASI240517C130000
- 0.39
- 0.000.00%
15min DelayClose May 14 09:53 ET
0.00High0.00Low
0.00Open0.39Pre Close0 Volume0 Open Interest130.00Strike Price0.00Turnover538.87%IV4.52%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.39Time Value100Contract SizeAmericanOptions Type0.1450Delta0.0427Gamma319.87Leverage Ratio-26.0167Theta0.0000Rho46.37Eff Leverage0.0023Vega
Masimo Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$Goldman Sachs(GS.US$ Shares of Goldman Sachs surged 3.3% in premarket trading following the company's earnings report, which exceeded Wall Street's first-quarter expectations. The firm reported earnings of $11.58 per share on revenue of $14.21 billion, surpassing analysts' predictions of $8.56 per share and revenue of $12.92 billion, thanks to the strong performance of its trading and investment banki...
Gapping up
$Goldman Sachs(GS.US$ Shares of Goldman Sachs surged 3.3% in premarket trading following the company's earnings report, which exceeded Wall Street's first-quarter expectations. The firm reported earnings of $11.58 per share on revenue of $14.21 billion, surpassing analysts' predictions of $8.56 per share and revenue of $12.92 billion, thanks to the strong performance of its trading and investment banki...
26
1
Morning Movers
Gapping up
$Disney(DIS.US$ 's stock enjoyed a 1.2% increase after a company spokesperson responded to activist investor Nelson Peltz's criticisms regarding the company's movie casting choices, using it as a reason to argue against his appointment to Disney's board.
$Masimo(MASI.US$ 's stock surged by 13% on news from the Wall Street Journal that Politan Capital Management is looking to propose two additional m...
Gapping up
$Disney(DIS.US$ 's stock enjoyed a 1.2% increase after a company spokesperson responded to activist investor Nelson Peltz's criticisms regarding the company's movie casting choices, using it as a reason to argue against his appointment to Disney's board.
$Masimo(MASI.US$ 's stock surged by 13% on news from the Wall Street Journal that Politan Capital Management is looking to propose two additional m...
33
1
Politan supports a review of Masimo's consumer business but expresses concerns over the company's corporate governance and doubts about the follow-through on the separation. Politan also feels that its directors have been marginalized by Kiani since joining the board.
1
massive shout out to my friend @Buffalo who called this out! 👏
I was just lucky enough to buy
$Masimo(MASI.US$
I was just lucky enough to buy
$Masimo(MASI.US$
6
Analysts predict a substantial slowdown in Masimo's revenue growth, with expectations of 2.6% annual growth until 2024, compared to a past rate of 21%. The wider industry is expected to outpace Masimo.
Despite EPS decline, market optimism persists for long-term earnings stability. Current sell-off could be a worthy opportunity if fundamentals indicate sustainable growth. Yet, two warning signs exist in Masimo's investment analysis, one being concerning.
The import ban could significantly impact Apple's competitiveness in the US smartwatch market and its overall financial performance. The ongoing legal dispute underscores the complexities of patent litigation in the tech industry and could potentially strengthen Masimo's position in the health tech market.
1
The patent dispute with Masimo highlights the challenges Apple may face as it expands further into the health market, where established players and device makers may engage in prolonged patent disputes with the company.
2
The import ban may hit Apple's smartwatch sales in the U.S., and the ongoing legal fight with Masimo could further stress the company's resources and reputation. The appeal process, expected to last over a year, could extend the uncertainty around Apple's smartwatch business.
Big moves off of this news headline.
$Masimo(MASI.US$
There is a nice gap that might get filled.
$Apple(AAPL.US$ $SPDR S&P 500 ETF(SPY.US$ $iShares Russell 2000 ETF(IWM.US$
$Masimo(MASI.US$
There is a nice gap that might get filled.
$Apple(AAPL.US$ $SPDR S&P 500 ETF(SPY.US$ $iShares Russell 2000 ETF(IWM.US$
No comment yet
104674846 : Saya tak paham bahasa inglesh